These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

540 related items for PubMed ID: 6338848

  • 1. Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease.
    Armitage JO, Dick FR, Goeken JA, Foucar MK, Gingrich RD.
    Arch Intern Med; 1983 Mar; 143(3):445-50. PubMed ID: 6338848
    [Abstract] [Full Text] [Related]

  • 2. Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease.
    Krikorian JG, Burke JS, Rosenberg SA, Kaplan HS.
    N Engl J Med; 1979 Mar 01; 300(9):452-8. PubMed ID: 366418
    [Abstract] [Full Text] [Related]

  • 3. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A, Trau H, David M, Feinmesser M, Bergman R, Shpiro D, Schiby G, Rosenblatt K, Or R, Hodak E.
    Br J Dermatol; 2006 Aug 01; 155(2):379-86. PubMed ID: 16882178
    [Abstract] [Full Text] [Related]

  • 4. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A, Medeiros LJ, Kingma DW, Longo DL, Jaffe ES.
    Am J Surg Pathol; 1993 Feb 01; 17(2):123-32. PubMed ID: 8422110
    [Abstract] [Full Text] [Related]

  • 5. Secondary malignancies in a child with Hodgkin's disease: T-cell lymphoma and myelodysplastic syndrome evolving into acute nonlymphoblastic leukaemia.
    Polychronopoulou S, Panagiotou JP, Papadakis T, Mavrou A, Anagnostou D, Haidas S.
    Med Pediatr Oncol; 1996 May 01; 26(5):359-66. PubMed ID: 8614370
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
    Wiernik PH, Dutcher JP, Einzig AI, Sparano J, Frank M, Friedenberg W.
    Cancer J Sci Am; 1998 May 01; 4(4):254-60. PubMed ID: 9689984
    [Abstract] [Full Text] [Related]

  • 13. Non-Hodgkin's lymphomas of the lung. A study of 19 cases emphasizing the utility of frozen section immunologic studies in differential diagnosis.
    Weiss LM, Yousem SA, Warnke RA.
    Am J Surg Pathol; 1985 Jul 01; 9(7):480-90. PubMed ID: 3879107
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The onset of double metachronous neoplasms 29 years after the diagnosis of Hodgkin's disease].
    Bisi D, Federico M, Sarti M, Barbieri F, Curci G.
    Minerva Med; 1989 May 01; 80(5):511-4. PubMed ID: 2747980
    [Abstract] [Full Text] [Related]

  • 17. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM, Anselmo AP, Donato V, Falchetto Osti M, Santoro M, Tombolini V, Mandelli F.
    Haematologica; 1999 Oct 01; 84(10):917-23. PubMed ID: 10509040
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.